145 related articles for article (PubMed ID: 22933681)
1. Correlation between a bone resorption marker and structural geometry of the proximal femur in osteoporotic women treated with raloxifene.
Takada J; Iba K; Yoshizaki T; Yamashita T
J Orthop Surg (Hong Kong); 2012 Aug; 20(2):209-13. PubMed ID: 22933681
[TBL] [Abstract][Full Text] [Related]
2. Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial.
Uusi-Rasi K; Beck TJ; Semanick LM; Daphtary MM; Crans GG; Desaiah D; Harper KD
Osteoporos Int; 2006; 17(4):575-86. PubMed ID: 16392026
[TBL] [Abstract][Full Text] [Related]
3. The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis.
Beck TJ; Fuerst T; Gaither KW; Sutradhar S; Levine AB; Hines T; Yu CR; Williams R; Mirkin S; Chines AA
Bone; 2015 Aug; 77():115-9. PubMed ID: 25917574
[TBL] [Abstract][Full Text] [Related]
4. Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis.
Takada J; Miki T; Imanishi Y; Nakatsuka K; Wada H; Naka H; Yoshizaki T; Iba K; Beck TJ; Yamashita T
J Bone Miner Metab; 2010 Sep; 28(5):561-7. PubMed ID: 20333418
[TBL] [Abstract][Full Text] [Related]
5. [Effects of SERMs on bone health. The effects of raloxifene on bone quality evaluated by hip structure analysis].
Takada J; Iba K; Yamashita T; Yoshizaki T
Clin Calcium; 2010 Mar; 20(3):355-63. PubMed ID: 20190365
[TBL] [Abstract][Full Text] [Related]
6. Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?
LaCroix AZ; Beck TJ; Cauley JA; Lewis CE; Bassford T; Jackson R; Wu G; Chen Z
Osteoporos Int; 2010 Jun; 21(6):919-29. PubMed ID: 19756830
[TBL] [Abstract][Full Text] [Related]
7. Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis.
Ito M; Sone T; Fukunaga M
J Bone Miner Metab; 2010 May; 28(3):334-41. PubMed ID: 19937358
[TBL] [Abstract][Full Text] [Related]
8. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.
Uusi-Rasi K; Semanick LM; Zanchetta JR; Bogado CE; Eriksen EF; Sato M; Beck TJ
Bone; 2005 Jun; 36(6):948-58. PubMed ID: 15878318
[TBL] [Abstract][Full Text] [Related]
9. Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate.
Beck TJ; Lewiecki EM; Miller PD; Felsenberg D; Liu Y; Ding B; Libanati C
J Clin Densitom; 2008; 11(3):351-9. PubMed ID: 18495508
[TBL] [Abstract][Full Text] [Related]
10. Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometry.
Briot K; Benhamou CL; Roux C
J Clin Densitom; 2012; 15(2):176-85. PubMed ID: 22321661
[TBL] [Abstract][Full Text] [Related]
11. Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Moriishi M; Kawanishi H; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():62-6. PubMed ID: 21595855
[TBL] [Abstract][Full Text] [Related]
12. The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk.
Sone T; Ito M; Fukunaga M; Tomomitsu T; Sugimoto T; Shiraki M; Yoshimura T; Nakamura T
Bone; 2014 Jul; 64():75-81. PubMed ID: 24727160
[TBL] [Abstract][Full Text] [Related]
13. Combined use of ibandronate and eldecalcitol in postmenopausal Japanese women with osteoporosis.
Takada J; Wada H; Iba K; Sasaki K; Dohke T; Kanaya K; Yoshizaki T; Yamashita T
J Orthop Surg (Hong Kong); 2016 Dec; 24(3):362-366. PubMed ID: 28031507
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B; San Martin J; Crans G; Pavo I
J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
[TBL] [Abstract][Full Text] [Related]
15. Effect of Tissue-Selective Estrogen Complex on Hip Structural Geometry in Postmenopausal Women: A 12-Month Study.
Kim BM; Kim SE; Lee DY; Choi D
Front Endocrinol (Lausanne); 2021; 12():649952. PubMed ID: 33776942
[TBL] [Abstract][Full Text] [Related]
16. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.
Greenspan SL; Beck TJ; Resnick NM; Bhattacharya R; Parker RA
J Bone Miner Res; 2005 Sep; 20(9):1525-32. PubMed ID: 16059624
[TBL] [Abstract][Full Text] [Related]
17. [The changes in bone geometric parameters by medication].
Takada J; Iba K; Yamashita T
Clin Calcium; 2013 Jul; 23(7):1041-8. PubMed ID: 23811594
[TBL] [Abstract][Full Text] [Related]
18. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
Brixen K; Chapurlat R; Cheung AM; Keaveny TM; Fuerst T; Engelke K; Recker R; Dardzinski B; Verbruggen N; Ather S; Rosenberg E; de Papp AE
J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
[TBL] [Abstract][Full Text] [Related]
19. Adherence to raloxifene therapy: assessment methods and relationship with efficacy.
Finigan J; Naylor K; Paggiosi MA; Peel NF; Eastell R
Osteoporos Int; 2013 Nov; 24(11):2879-86. PubMed ID: 23695420
[TBL] [Abstract][Full Text] [Related]
20. Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis.
Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
Endocr J; 2008 Mar; 55(1):41-8. PubMed ID: 18187874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
